Flavopiridol: where do we stand in chronic lymphocytic leukemia?


The findings presented by Dr Billard and his co-workers in a previous issue of Leukemia (‘Flavopiridol downregulates the expression of both the inducible NO synthase and p27 in malignant cells from B-cell chronic lymphocytic leukemia’) serve to shed more light on the mechanism of action of flavopiridol in B-CLL. In particular, this paper identifies two new… (More)
DOI: 10.1038/sj.leu.2403237